COMMUNIQUÉS West-GlobeNewswire

L’Association canadienne pour l’équité en santé des femmes et GreenShield lancent un partenariat en faveur de la recherche et du soutien dans le domaine de la santé des femmes dans la cinquantaine
10/08/2026
Ce partenariat national aidera à produire des données probantes et à améliorer les ressources de sensibilisation, d’éducation et de soutien pour les femmes vivant la transition vers la ménopause au Canada TORONTO, 10 [...]
Compass Health to purchase Friday Harbor facility from San Juan County, supporting behavioral health care in the islands long-term
10/08/2026
State funding and a decades-long county partnership secure the building's future FRIDAY HARBOR, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Compass Health is purchasing its Friday Harbor facility located at 520 Spring [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026
10/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2026
10/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
10/08/2026
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]
Metabio Advances Global Preventive Healthcare with Integrated AI-Powered Bioresonance Ecosystem
10/08/2026
HONG KONG, Aug. 10, 2026 (GLOBE NEWSWIRE) -- As global healthcare priorities increasingly shift from reactive treatment to proactive wellness management, health technology enterprise Metabio today announced the [...]
NTG Nordic Transport Group publishes interim report for H1 2026
10/08/2026
Company announcement no. 29 – 26 10 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026 The interim report for H1 2026 is enclosed. In connection with publication of the results for H1 2026, a [...]
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
10/08/2026
Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
New research explores how data can help detect disease earlier and improve patient care
10/08/2026
VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Every patient has a story, yet no single source of health information tells the whole story. What if researchers could use data to identify multiple [...]
NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears
10/08/2026
Topline Results from Intranasal NEO100 in Recurrent IDH1-mutant High-grade Glioma could mark a Major Clinical Catalyst for NeOnc DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) – NeOnc Technologies (NASDAQ: NTHI [...]
ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11)
10/08/2026
No clinical safety or efficacy issues identified and no additional clinical or nonclinical data requested The Complete Response Letter for the ongoing ITM-11 New Drug Application (NDA) cites Chemistry, Manufacturing and [...]
Novo Nordisk A/S - share repurchase programme
10/08/2026
Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
10/08/2026
Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governance Appointment further strengthens [...]
Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics
10/08/2026
Acquisition of the GMP biologics manufacturing facility expands Xcellon’s integrated capabilities from discovery through clinical supply and strengthens U.S. biomanufacturing BELTSVILLE, Md., Aug. 10, 2026 (GLOBE [...]
PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ
10/08/2026
AI answering service draws on 30 years of clinical workflow expertise and features the first application of Sloane, PerfectServe’s virtual AI agent MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Most answering services can [...]
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
10/08/2026
Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology Initial DREAM Study Results Anticipated in Q4 2026 SOLANA BEACH, Calif., Aug. 10, 2026 ( [...]
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
10/08/2026
Applied Biologics believes rigorous scientific development and regulatory standards are essential to advancing innovation in chronic wound care SCOTTSDALE, Ariz., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
10/08/2026
Completed Enrollment and Ampligen Dosing in Metastatic Pancreatic Cancer Phase 2 Trial, Positioning Company for Key Clinical Milestones Through Early 2027 Pancreatic Cancer Remains Strategic Priority as AIM Advances [...]
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
10/08/2026
– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action – – Findings demonstrate differentiated menin binding and activity against [...]

Pages